|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Rituximab plus gemcitabine, ifosfamide, oxaliplatin (R-GIFOX) as salvage therapy for recurrent Hodgkin lymphoma显示文摘 | Corazzelli G Frigeri F Mareacci G | 2009 | J Clin Oncol2009，27，： | 1 |
| 2 | Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma显示文摘 | Corazzelli G Capobianco G | | 0，，： | 1 |
| 3 | Pentostatin (2'-deoxycoformycin) for the treatment of hepatosplenic γδ T-cell lymphomas显示文摘 | Corazzelli G Capobianco G Russo F | 2005 | Haematologica2005，90，3： | 1 |
| 4 | Long-term result of gemcit-abine plus oxaliplatin without rituximab as salvage treatment for transplantineligible patients with refractory/relapsing B-cell lymphoma显示文摘 | Corazzelli G Capobianco G Arcamone M | 2009 | Cancer Chemother Pharmacol2009，64，5： | 1 |
| 5 | Gemcitabine,ifosfamide,oxaliplatin (GIFOX) as first-line treatment in high-risk peripheral T-Cell/NK lymphomas:a phase Ⅱ trial显示文摘 | Corazzelli G Frigeri F Marcacci G | 2010 | Blood2010，116，： | 1 |
| 6 | Gemcitabine, ifosfamide, oxaliplatin (GIFOX) as first-line treatment in high-risk peripheral T-Cell/NK lymphomas: a phase II trial显示文摘 | Corazzelli G Marcacci G Frigeri F | 2010 | Blood2010，116，21： | 1 |
| 7 | Pentostatin ( 2'-deoxyeofor- myein) for the treatment of hepatosplenic gammadeha T-cell lympho- mas 显示文摘 | Corazzelli G Capobianco G Russo F | 2005 | Haematologiea2005，90，3： | 1 |
| 8 | RD-CODOX-M/IVAC with ritux- imab and intrathecal liposomal cytarabine in adult Burkitt lympho- ma and 'unclassifiable' highly aggressive B-cell lymphoma显示文摘 | Corazzelli G Frigeri F Russo F | 2012 | Br J Haematol2012，256，2： | 1 |
| 9 | Dose-dense(dd) ABVD and dose-dense/dose-intense (dd-di) ABVD in newly diagnosed patients (pts), intermediate- and advanced-stage with classical Hodgkin' s lym- phoma ( cHL ) : final results 显示文摘 | Russo F Corazzelli G Lastoria S | 2009 | Blood2009，114，22： | 1 |
| 10 | Long- term Tesuhs of Gemeitabine plus Oxaliplatin with and without Rituximab as Salvage Treatment for Transplant- ineligible Patients with Refractory/relapsing B-cell lymphoma显示文摘 | Corazzelli G1 Capobiancn G Arcamone M | 2009 | Cancer Chemother Pharmaeol2009，64，5： | 1 |
| 11 | RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and ' unclassifiable' highly aggressive B-cell lymphoma 显示文摘 | Corazzelli G Frigeri F Russo F et at | 2012 | Br J Haematol2012，156，2： | 1 |
| 12 | Gemcitabine, ifosfamide, oxaliplafin and rituximab (R-GIFOX), a new effective cytoreductive/mobilizing salvage regimen for relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a pilot study显示文摘 | Corazzelli G Russo F Capoblanco G | 2006 | Ann Oncol2006，174，： | 1 |
| 13 | Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma显示文摘 | Corazzelli G Capobianco G Arcamone M | | 0，，： | 1 |
| 14 | Long-term results of Gemcitabine plus Oxaliplatin with and without Rituximab as salvage treatment for transplant-ineligible patients with refraetory/relapsing B-cell lymphoma 显示文摘 | Corazzelli G Capobianco G Arcamone M | 2009 | Cancer Chemother Pharmacol2009，64，5： | 1 |
| 15 | MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas显示文摘 | A J.M. Ferreri S Dell’Oro M Foppoli M Bernardi A A. Brandes A Tosoni M Montanari M Balzarotti M Spina F Ilariucci F Zaja C Stelitano F Bobbio G Corazzelli L Baldini M Ponzoni P Picozzi F Caligaris Cappio M Reni | 2006 | Neurology2006，，9： | 1 |
| 16 | Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma显示文摘 | Corazzelli G Capobianco G Arcamone M | 2009 | Cancer Chemother Pharmacol2009，64，5： | 1 |
| 17 | Thyroid lymphoma:early clinical suspicion may be critical for cure显示文摘 | Chiofalo MG Corazzelli G Franco R | | 0，，： | 1 |
| 18 | Gemcitabine,ifosfamide,oxaliplatin and rituximab (R-GIFOX), a new effective cytoreductive/mobilizing salvage regimen for relapsed and refractory aggressive non-Hodgkin' s lymphoma: results of a pilot study显示文摘 | Corazzelli G Russo F Capobianco G | | 0，，4： | 1 |
| 19 | Dose-dense (dd) ABVD and dose-dense/dose-intense (dd-di) ABVD in newly diagnosed patients (pts),intermediate-and advanced-stage with classical Hodgkin's lymphoma (cHL):finalresults显示文摘 | Russo F Corazzelli G Lastoria S | 2009 | Blood2009，114，22： | 1 |
| 20 | Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma显示文摘 | Corazzelli G Capobianco G Arcamone M | 2009 | Cancer Chemother Parmacol2009，64，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员